Skip to main content

Emerging Therapies

Emerging Therapies
Adding the BCL-2 Inhibitor Venetoclax to Treatment Regimen Promising in Relapsed or Refractory Multiple Myeloma
Read More
Emerging Therapies, In the News
“Smart Bomb” First-in-Class Drug Rova-T Promising Novel Therapy for Small-Cell Lung Cancer
Read More
Emerging Therapies
The Oncology Drug Pipeline Shows No Evidence of Slowing Down
Read More
Emerging Therapies
The Hematologic Drug Pipeline: Exciting New Treatment Options Looming
Read More
Emerging Therapies
Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
Read More
Emerging Therapies
Venetoclax Shows Strong Activity in CLL
Read More
Emerging Therapies
Nivolumab Beats Docetaxel as Second-Line Therapy for Patients with NSCLC
Read More
Emerging Therapies
Oncology Pipeline Full, and Not Just with Immunotherapies
Read More
Emerging Therapies
CAR-T Cells: The Transplants of the Future
Read More
Emerging Therapies
Encouraging Results for Pembrolizumab in Head and Neck Cancer
Read More
Page 4 of 7
Results 31 - 40 of 67